Urgent: 7 year old boy needs lifesaving med, Big Pharma Chemerix will not release drug
A little 7 year old boy lies on his death bed today. He reportedly has about a week to live and is dying with a preventable disease. A Big Pharma company Chemerix will not release the drug Brincidofovir to this child, at this time the only known drug that could save his life.
Josh Hardy, who has battled cancer for the last two years has developed a secondary infection as a result of that treatment.
The pathogen that has entered his blood stream is called Adenovirus. This virus is usually overcome easily with patients with a normal immune system. Pink eye is a form of Adenovirus.
Josh does not have a normal functioning immune system, he is still very sick from a bone marrow transplant he had recently as part of his ongoing treatment.
Doctors at St. Jude recommended Josh be treated with Brincidofovir – an antiviral drug that has been proven to clear up adenovirus in children within two weeks
However, Brincidofovir, the only known treatment for Josh is in stage 3 trials awaiting FDA approval and is in the hands of drug maker Chemerix.
I am confident the reason Chemerix is not releasing this drug is that they are protecting their investment. The drug is reportedly on the brink of approval and because of successful trials the drug has been requested to be placed on the FDA “fast track”, a common occurrence when the drug shows promise of saving lives if implemented and approved quickly.
What could be worse than a drug company giving this drug to a child outside a trial and it not work as stated? But the company has already stated the drug works and well enough for an FDA fast track.
You would think the oncoming high profile nature of this case will surely outweigh Chemerixs concerns over whether it works or not or whether their bottom line will be affected.
After all, Chemerix stands to profit billions once the FDA approval process is completed. God forbid a little dying boy stand in the way of a company and it’s profits.
Chemerix CEO Kenneth I. Moch has said in several interviews that it is a cost issue and has recently been quoted as saying it is an ethical decision that if he does it for this kids many more will come forward. And the drug was developed for what reason?
If Chemerix’s CEO had stepped back and thought about this a moment and changed his direction the public would be clamoring to get this drug on the market, praising this company and its innivation,begging for fast FDA approval to save this little boys life, but instead the public is calling for the removal of their big capitalist heads.
There is something unique about Americans in that they can somehow manage put all indifferences aside and rally around a little boy dying from a curable infection and face a large corporation withholding the cure. I love this about America.
A private individual has offered the 50,000 dollars it would cost to treat this individual and Chemerix once again denied to treat the young dying boy.
The family of young Josh Hardy is asking now for Chemerix to allow a compassionate user request which would facilitate Josh getting the treatment he needs bypassing FDA approval. This is where you are needed. To date, nearly 900 patients in trial have been treated with this drug thus far.
March 7th, 2014, Chemerix released this statement on their website. To me it shows how close they are to releasing this drug for approval, assuring the safety of it’s delivery.
“We are enthusiastic about brincidofovir’s potential to prevent clinically significant viral infections in bone marrow transplant recipients, and look forward to expanding the compound’s development activities to other DNA viruses and other patient populations, (to include Adenovirus in immunocompromised patients) said Kenneth I. Moch, President and CEO of Chimerix….. we are working to prepare our pre-launch strategies and to establish our commercial infrastructure.”
Interestingly, Chemerix has received 72 million in federal tax dollars to research this drug to fruition. Chemerix also reported a near 900 percent profit margin for 2013 which formulates to 10s of millions in profit for the pharmaceutical company.
In summary, a little 7 year old boy is dying and has reportedly a week to live with a treatable disease. A big Pharmaceutical company has the cure, Chemerix refuses to offer the drug that may save his life and the companies profit margin and ethical dilemmas are being cited as reasons for their denial.
Good Lord help us all! Bare grassroots people like you and I can make a difference.
We can call and demand the result we want especially as our tax dollars are being used to develop the drug needed for this young boy and being held from him.
Let’s see if we an make a difference! Spread the word. Contact the numbers below.
My call to Chemerix has been unanswered as yet but I did leave a message. Let’s jam up the phone and email lines and see if we can save this young boys life.
To contact Chemerix and support this young boy and perhaps save his life, give Chemerix a call and spread the word to your social networking friends on Facebook and Twitter.
To help save Josh, I encourage supporters to call
Chimerix at 919-806-1074;
supporters can also e-mail
tweet @chimerix using the hashtag #savejosh
Contact the Chimerix Board of Directors at
Show your support for Josh and his family at this website
Profit Margin report for Chemerix 2013
Chemerix number one campaign donation goes to Barrack Hussein Obama. 1.3 million in lobbying.